Bernabeu-Wittel, José <br/><br/>
Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.  [electronic resource] 

 -  Pediatric dermatology   
 - 853-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1525-1470 
<br/><br/><label>Standard No.: </label>10.1111/pde.12686  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Chi-Square Distribution<br/>Child, Preschool<br/>Cohort Studies<br/>Confidence Intervals<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Hemangioma, Capillary--congenital<br/>Humans<br/>Infant<br/>Male<br/>Nadolol--administration & dosage<br/>Patient Safety<br/>Prognosis<br/>Propranolol--adverse effects<br/>Retrospective Studies<br/>Skin Neoplasms--congenital<br/>Sleep Wake Disorders--chemically induced<br/>Treatment Outcome<br/>Withholding Treatment